Bentham Science Publishers logo

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

More like this?
Volume 4, Number 2, April 2005
Content Key:
Free Content - Free
New Content - New
Open Access Content - Open Access
Subscribed Content - Subscribed
Free Trial Content - Free Trial

< previous issue | next issue > | all issues

Book review

Editorial [Hot Topic: Therapeutic Approaches in the Treatment of Stroke (Guest Editor: Kevin Pong)]
pp. 107-107(1)
Author: Pong, Kevin

Review article

Free Radical Trapping as a Therapeutic Approach to Neuroprotection in Stroke: Experimental and Clinical Studies with NXY-059 and Free Radical Scavengers
pp. 109-118(10)
Authors: Green, A. R.; Ashwood, Tim

Repinotan, A 5-HT1A Agonist, in the Treatment of Acute Ischemic Stroke
pp. 119-120(2)
Author: Lutsep, Helmi L.

Growth Factor Treatment of Stroke
pp. 121-125(5)
Authors: Ren, Jing M.; Finklestein, Seth P.

Arundic Acid (ONO-2506) Ameliorates Delayed Ischemic Brain Damage by Preventing Astrocytic Overproduction of S100B
pp. 127-142(16)
Authors: Asano, T.; Mori, T.; Shimoda, T.; Shinagawa, R.; Satoh, S.; Yada, N.; Katsumata, S.; Matsuda, S.; Kagamiishi, Y.; Tateishi, N.

NMDA/NR2B Selective Antagonists in the Treatment of Ischemic Brain Injury
pp. 143-151(9)
Authors: Wang, Chen X.; Shuaib, Ashfaq

AMPA Receptor Antagonists for the Treatment of Stroke
pp. 153-159(7)
Author: Weiser, Thomas

Therapeutic Potential of TACE Inhibitors in Stroke
pp. 161-168(8)
Authors: Lovering, F.; Zhang, Y.

Estrogens as Protectants of the Neurovascular Unit Against Ischemic Stroke
pp. 169-177(9)
Authors: Yang, Shao-Hua; Liu, Ran; Perez, Evelyn J.; Wang, Xiaofei; Simpkins, James W.

Poly (ADP-Ribose) Polymerase Inhibitors as Potential Therapeutic Agents in Stroke and Neurotrauma
pp. 179-194(16)
Authors: Komjati, Katalin; Besson, Valerie C.; Szabo, Csaba

Pharmacological Approaches to Functional Recovery After Spinal Injury
pp. 195-210(16)
Author: Parker, David

Glutamate Transporters as Drug Targets
pp. 211-220(10)
Authors: Hinoi, Eiichi; Takarada, Takeshi; Tsuchihashi, Yuriko; Yoneda, Yukio

< previous issue | next issue > | all issues

Content Key:
Free Content - Free
New Content - New
Open Access Content - Open Access
Subscribed Content - Subscribed
Free Trial Content - Free Trial
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in
Need to register?
Sign up here
Text size: A | A | A | A